Thermal ablation of CT ‘invisible’ liver tumors using MRI fusion: a case control study

References

• Samanci C, Sobhani F, Ucbilek E, et al. Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review. Ann Transplant. 2016;21:68–76.
   PubMed Web of Science ®Google Scholar
• Choi SH, Lee JM, Yu NC, et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. Ajr. 2008;191(2):529–536.
   PubMed Web of Science ®Google Scholar
• Di Martino M, Marin D, Guerrisi A, et al. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 2010;256(3):806–816.
   PubMed Web of Science ®Google Scholar
• Akai H, Kiryu S, Matsuda I, et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011;80(2):310–315.
   PubMed Web of Science ®Google Scholar
• Minami Y, Minami T, Hagiwara S, et al. Ultrasound–ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma. Eur Radiol. 2018;28(5):1986–1993.
   PubMed Web of Science ®Google Scholar
• Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136–143.
   PubMedGoogle Scholar
• Bale R, Widmann G, Stoffner DI. Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol. 2010;75(1):32–36.
   PubMed Web of Science ®Google Scholar
• Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34(4):852–856.
   PubMed Web of Science ®Google Scholar
• Bale R, Widmann G, Schullian P, et al. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol. 2012;22(4):930–937.
   PubMed Web of Science ®Google Scholar
• Schullian P, Johnston EW, Putzer D, et al. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study. Int J Hyperthermia. 2019;36(1):876–885.
   PubMed Web of Science ®Google Scholar
• Omary RA, Bettmann MA, Cardella JF, Society of Interventional Radiology Standards of Practice Committee, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol. 2003;14 (9 Pt 2):S293–S295.
   PubMedGoogle Scholar
• Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–2472.
   PubMed Web of Science ®Google Scholar
• van Amerongen MJ, Jenniskens SFM, van den Boezem PB, et al. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases – a meta-analysis. HPB (Oxford). 2017;19(9):749–756.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–968.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes – a 10-year experience at a single center. Radiology. 2016;278(2):601–611.
   PubMed Web of Science ®Google Scholar
• Bale R, Putzer D, Schullian P. Local treatment of breast cancer liver metastasis. Cancers (Basel). 2019;11(9):1341.
   PubMed Web of Science ®Google Scholar
• Fairweather M, Swanson R, Wang J, et al. Management of neuroendocrine tumor liver metastases: long-term outcomes and prognostic factors from a large prospective database. Ann Surg Oncol. 2017;24(8):2319–2325.
   PubMed Web of Science ®Google Scholar
• Mohan H, Nicholson P, Winter DC, et al. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol. 2015;26(7):935–942.e1.
   PubMed Web of Science ®Google Scholar
• Karabulut K, Akyildiz HY, Lance C, et al. Multimodality treatment of neuroendocrine liver metastases. Surgery. 2011;150(2):316–325.
   PubMed Web of Science ®Google Scholar
• Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1):235–240.
   PubMed Web of Science ®Google Scholar
• Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129(1):122–130.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gonen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
   PubMed Web of Science ®Google Scholar
• Luo W, Zhang Y, He G, et al. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World J Surg Onc. 2017;15(1):126. Available at https://doi.org/10.1186/s12957-017-1196-2.
   PubMed Web of Science ®Google Scholar
• Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104(13):1775–1784.
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis. 2013;31(5–6):485–489.
   PubMed Web of Science ®Google Scholar
• Xu ZF, Xie XY, Kuang M, et al. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance. J Clin Ultrasound. 2014;42(6):321–330.
   PubMed Web of Science ®Google Scholar
• Garcia-Blazquez V, Vicente-Bartulos A, Olavarria-Delgado A, EBM-Connect Collaboration, et al. Accuracy of CT angiography in the diagnosis of acute gastrointestinal bleeding: systematic review and meta-analysis. Eur Radiol. 2013;23(5):1181–1190.
   PubMed Web of Science ®Google Scholar
• Vreugdenburg TD, Ma N, Duncan JK, et al. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis. Int J Colorectal Dis. 2016;31(11):1739–1749.
   PubMed Web of Science ®Google Scholar
• Barkhausen J, Kahn T, Krombach GA, et al.; German Association of Chairmen in Academic Radiology (KLR). White paper: interventional MRI: current status and potential for development considering economic perspectives, part 1: general application. Rofo. 2017;189(7):611–623.
   PubMedGoogle Scholar
• Widmann G, Schullian P, Haidu M, et al. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol. 2012;35(3):570–580.
   PubMed Web of Science ®Google Scholar